Carcinogenesis via BilIN, predominantly associated with tubular adenocarcinoma, is characterized by a negative expression of MUC2 and an increase in the expression of MUC1, indicating the MUC1-positive pathway. The gene discussed is MUC2; the disease is tubular adenocarcinoma.